Frederic Herve Simonin

Title: Frederic Herve Simonin: Innovator in Transgenic Research

Introduction

Frederic Herve Simonin is a notable inventor based in Bischheim, France. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic animals. His work focuses on modifying gene expressions to create innovative solutions for medical challenges.

Latest Patents

Simonin holds a patent for a transgenic animal whose expression of opiate receptors is modified. This invention involves the use of a non-human transgenic mammal, specifically designed to alter the expression of a gene coding for opiate receptors. The primary application of this invention is in the production of medicines aimed at treating various pathological conditions, including severe acute or chronic pain, drug addiction, and the prevention or treatment of transplant rejections. He has 1 patent to his name.

Career Highlights

Frederic Herve Simonin is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work at this institution has allowed him to explore innovative approaches to genetic engineering and its applications in medicine.

Collaborations

Throughout his career, Simonin has collaborated with esteemed colleagues, including Marianne Lemeur and Hans W D Matthes. These partnerships have contributed to the advancement of research in the field of transgenic technology.

Conclusion

Frederic Herve Simonin's contributions to transgenic research highlight the potential of genetic modifications in addressing critical health issues. His innovative work continues to pave the way for future advancements in medical treatments.